Notice2023-09519
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 4, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Survey of Syringe Services Programs (NSSSP). This data collection which proposes assess and monitor SSP operational characteristics and services, funding resources, community relations, and key operational and programmatic successes and challenges, and support timely analysis and dissemination of national program evaluation survey findings.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 86 (Thursday, May 4, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 86 (Thursday, May 4, 2023)]
[Notices]
[Pages 28552-28553]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-09519]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-1359; Docket No. CDC-2023-0034]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled National Survey of Syringe Services Programs (NSSSP). This data
collection which proposes assess and monitor SSP operational
characteristics and services, funding resources, community relations,
and key operational and programmatic successes and challenges, and
support timely analysis and dissemination of national program
evaluation survey findings.
DATES: CDC must receive written comments on or before July 3, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0034 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#a5cac8c7e5c6c1c68bc2cad3"><span class="__cf_email__" data-cfemail="2a4547486a494e49044d455c">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also
[[Page 28553]]
requires federal agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each new proposed collection, each proposed extension of existing
collection of information, and each reinstatement of previously
approved information collection before submitting the collection to the
OMB for approval. To comply with this requirement, we are publishing
this notice of a proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
The National Survey of Syringe Services Programs (NSSSP) (OMB
Control No. 0920-1359, Exp. 12/31/2024)--Revision--National Center for
HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention, Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The primary purpose of the National Survey of Syringe Services
Programs (NSSSP) is to strengthen and improve the ability of CDC and
local and state partners to monitor and evaluate syringe services
programs (SSPs) nationally, with the overall goal of supporting,
sustaining, and improving SSPs nationwide and reducing infectious
disease and other harms related to drug use. Findings from the 2020-
2021 survey successfully characterized operational characteristics and
services, funding resources, community relations, and key operational
successes and challenges. The 2022 survey is currently being
implemented. Revisions are being requested to address the increasing
number of SSPs nationwide, the changing landscape of drug use
nationally, additional SSP supplies and services provided, and ways in
which SSPs are developing strategies to address the needs of PWUD.
The project will include all SSPs that are listed in a publicly
available directory of all known SSPs in the United States maintained
by the North American Syringe Exchange Network (NASEN; <a href="https://nasen.org">https://nasen.org</a>). The project will also include SSPs in NASEN's directory
that do not wish to be publicly listed but have agreed to be contacted
for research purposes, SSPs belonging to NASEN's buyers' club that are
not part of the directory, respondents to prior RTI Arnold Ventures
Surveys of SSPs that are not part of NASEN's directory, and other SSPs
proactively identified through searching state health department
websites, funding agencies, state and regional networks, regional
conferences, partner organization networks or webinars and via social
media. SSPs will be sent a letter of invitation to participate in a 35-
minute program survey. Participating programs will have the option of
completing the survey via different modalities to enhance feasibility
and comfort in completing the survey, for example via the Research
Electronic Data Capture (REDCap) or a similarly secure web-based
application. Other modalities for survey administration will include a
coordinated telephone or videoconferencing interview. SSPs will be sent
reminder letters for an approximately six-month data collection period.
SSPs that do not respond to prior reminders will be sent one final
reminder, and if the SSP still does not want to participate, one
(optional) question on why the SSP did not complete the survey will be
offered. The survey will include questions on operational
characteristics and services, funding resources, community relations,
and key operational successes and challenges.
Approximately 800 SSPs will be able to participate in the survey.
We anticipate that approximately 20% of SSPs will decline to complete
the survey, yielding approximately 640 completed surveys per year.
However, given that it is challenging to predict future response rates,
we are requesting enough burden hours to allow 100% of SSPs to respond
to the survey. We estimate that it will take 35 minutes to complete the
survey, regardless of how the respondent chooses to complete it (i.e.,
self-administered online or interviewer-administered by phone or
videoconferencing).
CDC requests OMB approval for an estimated 494 annual burden hours.
There is no cost to respondents other than their time to participate.
Estimates of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondent Form name Number of responses per per response Total burden
respondents respondent (hours) (in hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs........ National Syringe 800 1 35/60 467
Services
Program
Evaluation
Survey.
Non-responding SSPs........... Non-Response 800 1 2/60 27
Survey Item.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 494
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2023-09519 Filed 5-3-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 4, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.